Maternal Infant Health Opioid Use
This infographic is a publication of the Centers for Disease Control and Prevention (CDC). November, 2022. https://www.cdc.gov/reproductivehealth/opioid-use-disorder-pregnancy/pdf/MMWR-Opioids-Use-Disorder-Pregnancy-Infographic-h.pdf
Opioid exposure in pregnancy is an increasingly common problem in the United States, and in Nebraska there is a large amount of variability with maternal opioid use. NPQICs unpublished data highlights the impact of education to the healthcare profession in decreasing prescriptions of opioids and increasing diagnoses of infants with Neonatal Opioid Withdrawal Syndrome (NOWS) when they have exposures. We know that early diagnosis of a newborn prior to leaving the hospital decreases mortality in this high risk population.
NPQICs Maternal Infant Health Opioid Project has two main objectives. The first is to provide education to health care providers and medication dispensaries regarding opioid prescription use in pregnancy, and the second is to help develop, enhance, and strengthen the ability of primary care providers to implement therapeutic interventions that can improve the health outcomes of families affected by prenatal opioid exposure.
NPQIC has partnered with the Academy of Pediatrics (AAP) and created an ECHO series that aims at supporting pediatric primary care practices by raising awareness of infants with prenatal opioid exposure (i.e., documented birth history) and family-focused anticipatory guidance based upon developmental surveillance and screening.
Project Resources
Opioid Use Disorders: Interventions for Community Pharmacists
This infographic is a publication of the Centers for Disease Control and Prevention (CDC). November, 2022. https://www.cdc.gov/reproductivehealth/opioid-use-disorder-pregnancy/pdf/MMWR-Opioids-Use-Disorder-Pregnancy-Infographic-h.pdf
